# Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer

> **NCT01046461** · PHASE2 · UNKNOWN · sponsor: **Hallym University Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Solid Tumour
- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Ramosetron, Aprepitant, Dexamethasone

## Key facts

- **NCT ID:** NCT01046461
- **Lead sponsor:** Hallym University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046461, "Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01046461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*